Company Valuation: Abbott Laboratories

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 2,41,365 1,91,427 1,91,088 1,96,184 2,17,859 1,64,427 - -
Change - -20.69% -0.18% 2.67% 11.05% -24.53% - -
Enterprise Value (EV) 1 2,49,166 1,98,318 1,98,871 2,02,693 2,22,266 1,76,116 1,73,284 1,69,386
Change - -20.41% 0.28% 1.92% 9.66% -20.76% -1.61% -2.25%
P/E 35.7x 28.1x 33.8x 14.8x 33.7x 23.3x 19.9x 17.4x
PBR 6.93x 5.2x 4.94x 4.11x 4.18x 3.32x 3.19x 2.97x
PEG - -36.9x -2x 0x -0.7x 2.68x 1.2x 1.2x
Capitalization / Revenue 5.6x 4.39x 4.76x 4.68x 4.91x 3.27x 3x 2.81x
EV / Revenue 5.78x 4.54x 4.96x 4.83x 5.01x 3.5x 3.17x 2.89x
EV / EBITDA 19.4x 15.9x 19.5x 19.1x 18.9x 13.1x 11.9x 10.6x
EV / EBIT 22x 17.7x 22.3x 21.8x 21.6x 15.1x 13.3x 11.8x
EV / FCF 28.8x 25.4x 39.3x 31.9x 30.1x 20.3x 18.4x 16.3x
FCF Yield 3.47% 3.94% 2.54% 3.13% 3.33% 4.92% 5.44% 6.13%
Dividend per Share 2 1.82 1.92 2.08 2.24 2.4 2.547 2.715 2.866
Rate of return 1.29% 1.75% 1.89% 1.98% 1.92% 2.7% 2.88% 3.04%
EPS 2 3.94 3.91 3.26 7.64 3.72 4.043 4.736 5.437
Distribution rate 46.2% 49.1% 63.8% 29.3% 64.5% 63% 57.3% 52.7%
Net sales 1 43,075 43,653 40,109 41,950 44,328 50,256 54,748 58,610
EBITDA 1 12,815 12,485 10,188 10,635 11,735 13,414 14,578 15,961
EBIT 1 11,324 11,231 8,911 9,295 10,301 11,665 13,038 14,362
Net income 1 7,071 6,933 5,723 13,402 6,524 7,018 8,389 9,226
Net Debt 1 7,801 6,891 7,783 6,509 4,407 11,689 8,857 4,959
Reference price 2 140.74 109.79 110.07 113.11 125.29 94.40 94.40 94.40
Nbr of stocks (in thousands) 17,14,968 17,43,574 17,36,059 17,34,455 17,38,834 17,41,813 - -
Announcement Date 26/01/22 25/01/23 24/01/24 22/01/25 22/01/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
18.68x3.26x11.5x3.6% 11TCr
16.63x0.19x11.89x0.78% 5.88TCr
31.32x7.59x19.84x1.28% 5.11TCr
37.59x2.99x10.28x2.55% 4.16TCr
39.11x1.42x12.47x0.2% 3.45TCr
29.83x5.32x16.95x-.--% 2.82TCr
42.48x7.36x26.56x0.25% 2.53TCr
19.69x2.72x10.58x1.6% 2.02TCr
23.76x3.47x12.49x1.22% 2.11TCr
Average 28.79x 3.81x 14.73x 1.28% 4.29TCr
Weighted average by Cap. 26.60x 3.57x 14.00x 1.73%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. ABT Stock
  4. ABT Stock
  5. Valuation Abbott Laboratories